Y-Intercept (HK)
SLDB icon

Y-Intercept (HK)’s Solid Biosciences SLDB Stock Holding History

Y-Intercept (HK)’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$631K Sell
87,251
-22,635
-21% -$205K 0.01% 1214
2026
Q2 		$1.1M Buy
+109,886
New +$833K 0.02% 1012
2026
Q1 		– Sell
-36,147
Closed -$204K – 2012
2025
Q4 		$204K Buy
+36,147
New +$196K ﹤0.01% 1437
2024
Q3 		– Sell
-40,430
Closed -$229K – 1767
2024
Q2 		$229K Buy
+40,430
New +$362K 0.01% 1128

Other funds holding SLDB

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Y-Intercept (HK)'s SLDB Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Solid Biosciences (SLDB) stake by 21% in Q3 2026, selling an estimated $205K and leaving 87,251 shares worth $631K. The position accounts for 0.01% of the portfolio, ranked #1214.

Y-Intercept (HK) first reported a position in SLDB in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.1M in Q2 2026. 9 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • Y-Intercept (HK) held 87,251 shares of Solid Biosciences worth $631K as of Q3 2026.
  • Y-Intercept (HK) sold 22,635 Solid Biosciences shares in Q3 2026, an estimated $205K.
  • Solid Biosciences made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1214 holding.
  • Y-Intercept (HK) first reported a position in Solid Biosciences in Q2 2024 and has held it in 4 quarters since.
  • Y-Intercept (HK)'s Solid Biosciences position peaked at $1.1M in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.